Yaron Werber
Stock Analyst at TD Cowen
(2.56)
# 2,198
Out of 5,150 analysts
43
Total ratings
46.88%
Success rate
4.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Downgrades: Hold | $62 → $21 | $17.85 | +17.65% | 3 | Jan 22, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $15.05 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $21.80 | +244.04% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $41.69 | +22.33% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $749.56 | +52.89% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $79.45 | +24.61% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $2.15 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.33 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $299.02 | +11.70% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $31.76 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $62.03 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $28.83 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $241.38 | -36.61% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $103.80 | +17.53% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $7.80 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $34.42 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.42 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.17 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $29.54 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.76 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $28.18 | +34.85% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $29.52 | - | 1 | Oct 26, 2021 |
Legend Biotech
Jan 22, 2026
Downgrades: Hold
Price Target: $62 → $21
Current: $17.85
Upside: +17.65%
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $15.05
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $21.80
Upside: +244.04%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $41.69
Upside: +22.33%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $749.56
Upside: +52.89%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $79.45
Upside: +24.61%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.15
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.33
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $299.02
Upside: +11.70%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $31.76
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $62.03
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $28.83
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $241.38
Upside: -36.61%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $103.80
Upside: +17.53%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $7.80
Upside: -
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $34.42
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.42
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $5.17
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $29.54
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $8.76
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $28.18
Upside: +34.85%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $29.52
Upside: -